de Graeff PA - Search Results

1

Early ACE-inhibition in myocardial infarction. Possible role of bradykinin.

van Gilst WH, de Graeff PA. van Gilst WH, et al. Among authors: de graeff pa. Agents Actions Suppl. 1992;38 ( Pt 3):80-9. Agents Actions Suppl. 1992. PMID: 1462886 Review.

2

Effects of early angiotensin-converting enzyme inhibition in a pig model of myocardial ischemia and reperfusion.

van Wijngaarden J, Tobé TJ, Weersink EG, Bel KJ, de Graeff PA, de Langen CD, van Gilst WH, Wesseling H. van Wijngaarden J, et al. Among authors: de langen cd, de graeff pa. J Cardiovasc Pharmacol. 1992 Mar;19(3):408-16. doi: 10.1097/00005344-199203000-00017. J Cardiovasc Pharmacol. 1992. PMID: 1378122

3

The angiotensin converting enzyme inhibitor perindopril improves survival after experimental myocardial infarction in pigs.

Tobé TJ, de Langen CD, Weersink EG, van Wijngaarden J, Bel KJ, de Graeff PA, van Gilst WH, Wesseling H. Tobé TJ, et al. Among authors: de langen cd, de graeff pa. J Cardiovasc Pharmacol. 1992 May;19(5):732-40. J Cardiovasc Pharmacol. 1992. PMID: 1381771 Clinical Trial.

4

Captopril modifies the response of infarcted rat hearts to isoprenaline stimulation.

van Wijngaarden J, Monnink SH, Bartels H, van Gilst WH, de Graeff PA, de Langen CD, Wesseling H. van Wijngaarden J, et al. Among authors: de langen cd, de graeff pa. J Cardiovasc Pharmacol. 1992 May;19(5):741-7. J Cardiovasc Pharmacol. 1992. PMID: 1381772

5

Effects of converting enzyme inhibitors on coronary flow and myocardial ischemia.

van Gilst WH, Tio RA, van Wijngaarden J, de Graeff PA, Wesseling H. van Gilst WH, et al. Among authors: de graeff pa. J Cardiovasc Pharmacol. 1992;19 Suppl 5:S134-9. J Cardiovasc Pharmacol. 1992. PMID: 1381790 Review.

6

The effect of bradykinin on coronary flow and its potentiation by SH-containing ACE-inhibitors.

de Graeff PA, van Gilst WH. de Graeff PA, et al. Agents Actions Suppl. 1992;38 ( Pt 3):110-8. Agents Actions Suppl. 1992. PMID: 1462853 Review.

7

Converting enzyme inhibitors and the role of the sulfhydryl group in the potentiation of exo- and endogenous nitrovasodilators.

van Gilst WH, de Graeff PA, de Leeuw MJ, Scholtens E, Wesseling H. van Gilst WH, et al. Among authors: de leeuw mj, de graeff pa. J Cardiovasc Pharmacol. 1991 Sep;18(3):429-36. doi: 10.1097/00005344-199109000-00016. J Cardiovasc Pharmacol. 1991. PMID: 1720843 Clinical Trial.

8

Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.

van Wijngaarden J, Pinto YM, van Gilst WH, de Graeff PA, de Langen CD, Wesseling H. van Wijngaarden J, et al. Among authors: de langen cd, de graeff pa. Cardiovasc Res. 1991 Nov;25(11):936-42. doi: 10.1093/cvr/25.11.936. Cardiovasc Res. 1991. PMID: 1813122

9

The effects of short- and long-term treatment with an ACE-inhibitor in rats with myocardial infarction.

Pinto YM, van Wijngaarden J, van Gilst WH, de Graeff PA, Wesseling H. Pinto YM, et al. Among authors: de graeff pa. Basic Res Cardiol. 1991;86 Suppl 1:165-72. Basic Res Cardiol. 1991. PMID: 1827983

10

Coronary vasodilation induced by captopril and zofenoprilat: evidence for a prostaglandin-independent mechanism.

van Wijngaarden J, Tio RA, van Gilst WH, de Graeff PA, de Langen CD, Wesseling H. van Wijngaarden J, et al. Among authors: de langen cd, de graeff pa. Naunyn Schmiedebergs Arch Pharmacol. 1991 May;343(5):491-5. doi: 10.1007/BF00169551. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1881459

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters